• <sub id="naktq"><address id="naktq"><nobr id="naktq"></nobr></address></sub>
    <em id="naktq"></em>

      <sub id="naktq"><td id="naktq"><nobr id="naktq"></nobr></td></sub>

      1. <form id="naktq"><th id="naktq"><track id="naktq"></track></th></form>

        <wbr id="naktq"></wbr>

          <big id="naktq"><td id="naktq"></td></big><u id="naktq"><ins id="naktq"></ins></u>
          <form id="naktq"></form>

          INVENTING A NEW
          ROADMAP FOR BIOTECH

          Every day, we use our homegrown technologies to discover, develop, research and deliver new medicines that help people with serious diseases. Watch to see what drives us.

          Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

          Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite? technologies, such as VelocImmune? which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

          FOR 30 YEARS, OUR
          MISSION HAS BEEN TO
          USE THE POWER OF
          SCIENCE TO BRING
          NEW MEDICINES TO
          PATIENTS... OVER
          AND OVER AGAIN.

          Neil Stahl, PhD, Executive VP,
          Research and Development

          2018 annual report PDF download

          Check out our 2018 annual materials. The Responsibility Report and Annual Report are now online.

          Read our annual report
          and responsibility report

          2018 responsibility report PDF download

          REGENERON BY THE NUMBERS

          • 30
            years of scientific
            leadership
          • 8,100+
            employees
            worldwide
          • 700+
            employees with
            an MD, PhD or
            PharmD degree
          • 6TH
            consecutive year
            in Forbes’ World’s
            Most Innovative
            Companies
          • #1
            ranking in Science
            magazine’s global Top
            Employer survey for six
            of the past nine years
          • 31,000+
            employee volunteer hours
            for 100+ organizations
            in 2018
          • 7
            FDA-approved
            medicines
          • 98%
            of our waste
            diverted from
            landfill, surpassing
            our goal
          • 100%
            of drug candidates
            invented and
            developed in-house
          • 800,000+
            exomes sequenced
            to date
          • 100+
            publications in 2018
          • 20+
            product candidates in
            clinical development
            across multiple
            therapeutic areas
          • Fortune: Best Companies to Work for, 2020

            Newsweek, America’s Most Responsible Companies, 2020

            IDEA Pharma, Pharmaceutical Invention Index, 2019

            RobecoSAM and S&P Dow Jones Indices: Dow Jones Sustainability World Index, 2019

            Science: Top Employer, 2019

            Harvard Business Review: Best Performing CEOs, 2019

          • Civic 50: Most Community-Minded Companies in the Nation, 2019

            Fast Company: Best Workplaces for Innovators, 2019

            Shingo Institute: The Shingo Prize, 2019

            Great Places to Work: Best Workplace in Ireland, 2019

            Forbes: Top 10 Most Innovative Companies, 2018

          LEADERSHIP

          We are the only biopharmaceutical company to be led by physician-scientists for more than 30 years. We consistently demonstrate our commitment to scientific excellence by counting multiple Nobel Laureates and five members of the National Academy of Sciences among our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard.

          Our leadership

          A FOCUS
          ON SCIENCE

          From our first days, science has remained our central guiding principle.

          Our journey

          caoponrn免费公开视频